Your browser doesn't support javascript.
loading
Efficacy and safety of ledipasvir/sofosbuvir for hepatitis C among drug users: a systematic review and meta-analysis.
Yang, Xue; Tang, Yang; Xu, Di; Zhang, Guang; Xu, Peng; Tang, Houlin; Pang, Lin.
Afiliación
  • Yang X; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Tang Y; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Xu D; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhang G; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Xu P; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Tang H; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. tanghl@chinaaids.cn.
  • Pang L; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Virol J ; 18(1): 156, 2021 07 27.
Article en En | MEDLINE | ID: mdl-34315488
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Bencimidazoles / Hepatitis C / Consumidores de Drogas / Fluorenos / Sofosbuvir Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Virol J Asunto de la revista: VIROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antivirales / Bencimidazoles / Hepatitis C / Consumidores de Drogas / Fluorenos / Sofosbuvir Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Virol J Asunto de la revista: VIROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China